HPLC and the Future of Elastic Electronics
Scientists from the Institute of Physical Chemistry of the Polish Academy of Sciences (IPC PAS) have been undergoing a series of studies to learn more about the creation of thin layers of highly ordered polymers and how spectroscopy and HPLC can be used to create organic and elastic electronics.
Scientists from the Institute of Physical Chemistry of the Polish Academy of Sciences (IPC PAS) have been undergoing a series of studies to learn more about the creation of thin layers of highly ordered polymers and how spectroscopy and HPLC can be used to create organic and elastic electronics.
These thin organic materials, which will enable our future electronic devices to be made even thinner and lighter than they are now, are the future of electronics and will completely change the process of producing organic electronic systems.
“We have examined how the organization of molecules changes within layers, depending on the length of molecules. Thanks to this we understand why shorter molecules form ordered two-dimensional structures, while their long analogues create chaotic aggregates,” said Robert Nowakowski, the head of IPC PAS. “We can sometimes eliminate this last effect completely,” he added.
This new research into the production of organic materials will not only create thinner and lighter devices in the future, but will also cut down on the production costs of organic electronic systems, thus greatly reducing the price of such devices. Organic materials will allow electronic devices of the future to gain unprecedented properties such as the ability to be rolled into a tube or to produce it from transparent elements to be placed directly on surfaces such as car windows.
The production process currently being studied by the Microscopy and Spectroscopy Research Group at IPC PAS will hopefully open the doors for elastic electronics to hit the mass market sometime in the near future.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
